Data as of Dec 12
| -0.28 / -0.45%|
The 16 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 74.00, with a high estimate of 88.00 and a low estimate of 60.00. The median estimate represents a +20.09% increase from the last price of 61.62.
The current consensus among 22 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.